[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:
17-Jun-2014

[ | E-mail ] Share Share

Contact: Fiona Godwin
medicinepress@plos.org
PLOS

Transfusion after trauma can benefit or harm patients depending on their risk of death

The risks and benefits of red blood cell transfusions for patients with trauma and major bleeding might vary considerably based on a patient's predicted risk of death on arrival at a trauma centre, according to new research published in this week's PLOS Medicine. The study by Pablo Perel, from the London School of Hygiene & Tropical Medicine, United Kingdom, and colleagues, suggests that trauma patients who have the highest predicted risk of death on arrival at a trauma centre receive the greatest benefit from red blood cell transfusions but for those with the lowest predicted risk of death at baseline red blood cell transfusion is associated with a higher chance of death.

The authors of the study used data from the CRASH-2 trial that evaluated the effect of tranexamic acid (which reduces blood loss) in patients with trauma, which included 20,127 trauma patients with significant bleeding from 274 hospitals in 40 countries. The authors evaluated the association between receiving red blood cell transfusion versus not receiving a red blood cell transfusion with deaths by all causes at 28 days post trauma. The findings were stratified by predicted risk of death based on clinical observations on arrival at the trauma centre.

The authors found that those at greatest predicted risk of dying (>50%) had a smaller chance of death from all causes if they were transfused (an odds ratio (OR) of 0.59 (95% confidence interval [CI] 0.47-0.74)), while for those in the 21%-50% risk group there was no significant difference in their chance of dying based on whether they are transfused or not (OR 0.92, 95% CI 0.78-1.08). However, for those within the lower risk strata, transfusion was associated not with benefit but with harm. Patients at a 6%-20% chance of death had an OR of 2.31 (95% CI 1.96-2.73) for dying if they received a transfusion, while for those whose initial risk was below 6%, the OR for death associated with transfusion was 5.40 (95% CI 4.08- 7.13). In absolute figures, compared to no transfusion, RBC transfusion was associated with 5.1 (95% CI 4.3 to 6.0) more deaths per 100 patients in the patient group with the lowest predicted risk of death but with 11.9 (95% CI 7.1 to 16.7) fewer deaths per 100 patients in the group with the highest predicted risk of death.

The authors caution, "[o]ur study suggests that blood transfusion could be harmful for those patients whose predicted risk of death is low. However, as our study was observational, important biases cannot be ruled out, and we cannot claim a causal link. Therefore, this hypothesis should be prospectively evaluated in a randomised controlled trial."

In an accompanying Perspective article PLOS Medicine Consulting Editor Druin Burch notes, "[w]ith so many dying each year, and with deaths from injury set to rise in importance as road traffic crashes and violent injuries account for a greater portion of the global burden of disease, we have a compelling reason to improve and rationalize our transfusion strategies."

###

Research Article

Funding: This study was supported by PROGRESS Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership [G0902393/99558]. DA, PC and IR are UK NIHR Senior Investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.

Citation: Perel P, Clayton T, Altman DG, Croft P, Douglas I, et al. (2014) Red Blood Cell Transfusion and Mortality in Trauma Patients: Risk-Stratified Analysis of an Observational Study. PLoS Med 11(6): e1001664. doi:10.1371/journal.pmed.1001664

Author Affiliations:

London School of Hygiene & Tropical Medicine, UK
University of Oxford, UK
Keele University, UK
University College London, UK
The University of Melbourne, Australia
University of Birmingham, UK
London Chest Hospital

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001664

Contact:

Pablo Perel
London School of Hygiene & Tropical Medicine
UNITED KINGDOM
pablo.perel@lshtm.ac.uk

Perspective Article

Funding: Druin Burch is a Consulting Editor for PLOS Medicine and is paid by the Public Library of Science on a freelance basis.

Competing Interests: DB has helped with recruitment to the HALT-IT trial of tranexamic acid in upper gastrointestinal haemorrhages on behalf of the general medical service at the Oxford University Hospitals NHS Trust. The trial is not directly related to the CRASH-2 study but is coordinated by the same research unit. DB received no financial reward for his involvement in the HALT-IT trial.

Citation: Burch D (2014) Blood Transfusions following Trauma: Finding an Evidence-Based Vein. PLoS Med 11(6): e1001665. doi:10.1371/journal.pmed.1001665

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001665

Contact:

PLOS Medicine
plosmedicine@plos.org



[ Back to EurekAlert! ] [ | E-mail Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.